Chemed logo

CHE - Chemed News Story

$468.18 4.9  1.1%

Last Trade - 15/04/21

Sector
Healthcare
Size
Large Cap
Market Cap £5.43bn
Enterprise Value £5.31bn
Revenue £1.51bn
Position in Universe 1107th / 6851

BRIEF-Chemed Reports Fourth-Quarter 2020 Results

Tue 23rd February, 2021 9:28pm
Feb 23 (Reuters) - Chemed Corp  CHE.N :
    * CHEMED REPORTS FOURTH-QUARTER 2020 RESULTS
    * Q4 ADJUSTED EARNINGS PER SHARE $5.13
    * Q4 GAAP EARNINGS PER SHARE $6.96
    * Q4 REVENUE $533 MILLION VERSUS REFINITIV IBES ESTIMATE OF
$537.2
MILLION
    * SEES FY 2021 ADJUSTED EARNINGS PER SHARE $17.00 TO $17.50
EXCLUDING ITEMS
    * Q4 EARNINGS PER SHARE ESTIMATE $5.13 -- REFINITIV IBES
DATA
    * QTRLY  VITAS NET PATIENT REVENUE OF $332 MILLION, DECLINE
OF
2.3%
    * QTRLY  ROTO-ROOTER REVENUE OF $201 MILLION, AN INCREASE OF
10.2%
    * VITAS ANTICIPATES CONTINUED WEAK OCCUPANCY AND
CORRESPONDING
WEAK REFERRALS FROM SENIOR HOUSING FOR FIRST HALF OF 2021
    * ANTICIPATES SENIOR HOUSING OCCUPANCY WILL BEGIN TO
NORMALIZE TO
PRE-PANDEMIC OCCUPANCY STARTING IN SECOND HALF OF CALENDAR YEAR
2021
    * VITAS 2021 REVENUE IS ESTIMATED TO DECLINE APPROXIMATELY
4.0%
    * ROTO-ROOTER IS FORECASTED TO ACHIEVE FULL-YEAR 2021
REVENUE
GROWTH OF 5% TO 6%
    * FULL-YEAR 2021 ADJUSTED EARNINGS PER DILUTED SHARE IS
ESTIMATED
TO BE IN RANGE OF $17.00 TO $17.50

Source text for Eikon:  ID:nBw8VyC2ha 
Further company coverage:  CHE.N 

 ((Reuters.Briefs@thomsonreuters.com;))
© Stockopedia 2021, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.